Italian Consensus Conference on Epilepsy and Pregnancy, Labor and Puerperium

To facilitate an integrated and rational approach to the care of women with epilepsy of childbearing potential, a group of experts appointed by Italian scientific societies in the fields of epileptology, neonatology, pediatrics, neuropediatrics, child neuropsychiatry, obstetrics, and gynecology held a joint meeting in Santa Trada di Cannitello, Reggio Calabria, Italy, on October 15–16, 2004, with the aim of reaching consensus on the optimal management of these women. An ad hoc system for the classification of available published evidence and the opinions of experts was developed and used to grade recommendations on different aspects related to counseling, diagnostic, and treatment issues. The present document summarizes available evidence on the reciprocal interactions between epilepsy, antiepileptic drugs, fertility, contraception, pregnancy, delivery, breastfeeding, and the offspring. Recommendations are made concerning the information and counseling that should be provided to women with epilepsy with respect to issues related to contraception, conception, pregnancy, labour, and puerperium. More detailed recommendations on the same issues are provided to physicians and other healthcare professionals involved in the care of these women, with special reference to choice of effective contraception, optimization of antiepileptic drug therapy, use of prenatal diagnostic tests and other monitoring procedures, and appropriate management practices in relation to childbirth, puerperium, and the care of the child.

[1]  W. Hauser,et al.  Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes , 2009, Neurology.

[2]  C. Harden,et al.  Contraception for women with epilepsy. , 2009, Reviews in neurological diseases.

[3]  Clinical Excellence,et al.  Antenatal care : routine care for the healthy pregnant woman , 2008 .

[4]  C. Bearer Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .

[5]  T. Tomson,et al.  Pharmacokinetics and Therapeutic Drug Monitoring of Newer Antiepileptic Drugs During Pregnancy and the Puerperium , 2007, Clinical pharmacokinetics.

[6]  T. Tomson,et al.  Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives , 2006, Neurology.

[7]  J. Menzin,et al.  Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage , 2006, Neurology.

[8]  E. Perucca,et al.  Increased Apparent Oral Clearance of Valproic Acid during Intake of Combined Contraceptive Steroids in Women with Epilepsy , 2006, Epilepsia.

[9]  J. Guillebaud,et al.  Contraception for Women with Epilepsy , 2006, Epilepsia.

[10]  J. Simon,et al.  The impact of antiepileptic drug therapy on steroidal contraceptive efficacy , 2006, Epilepsy & Behavior.

[11]  H. Leonard,et al.  Maternal health in pregnancy and intellectual disability in the offspring: a population-based study. , 2006, Annals of epidemiology.

[12]  E. Perucca British Journal of Clinical Pharmacology Clinically Relevant Drug Interactions with Antiepileptic Drugs , 2022 .

[13]  S. Kochen,et al.  Seizure control and treatment in pregnancy , 2006, Neurology.

[14]  Lamotrigine possibly linked to cleft palate/lip, warns FDA , 2006 .

[15]  J. Detoledo Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. , 2006, Neurology.

[16]  T. Tomson Gender Aspects of Pharmacokinetics of New and Old AEDs: Pregnancy and Breast-Feeding , 2005, Therapeutic drug monitoring.

[17]  P. Crawford Best Practice Guidelines for the Management of Women with Epilepsy , 2005, Epilepsia.

[18]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  R. Kälviäinen,et al.  Children exposed to valproate in utero—Population based evaluation of risks and confounding factors for long-term neurocognitive development , 2005, Epilepsy Research.

[20]  A. Auvinen,et al.  Antiepileptic drug use of women with epilepsy and congenital malformations in offspring , 2005, Neurology.

[21]  M. O’Brien,et al.  Management of epilepsy in women , 2005, Postgraduate Medical Journal.

[22]  G. Baker,et al.  Neuropsychological effects of exposure to anticonvulsant medication in utero , 2005, Neurology.

[23]  L. Holmes,et al.  Increased rate of major malformations in offspring exposed to valproate during pregnancy , 2005, Neurology.

[24]  E. Wooltorton Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss , 2005, Canadian Medical Association Journal.

[25]  Í. Lopes-Cendes,et al.  Seizure frequency during pregnancy and the puerperium , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[26]  Catrin Tudur Smith,et al.  Common antiepileptic drugs in pregnancy in women with epilepsy. , 2015, The Cochrane database of systematic reviews.

[27]  M. Okada,et al.  Physical and Psychomotor Development in the Offspring Born to Mothers with Epilepsy , 2004, Epilepsia.

[28]  J. Clayton-Smith,et al.  A note on Pierre Marie (1853–1940) , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  T. Tomson,et al.  Navigating toward Fetal and Maternal Health: The Challenge of Treating Epilepsy in Pregnancy , 2004, Epilepsia.

[30]  N. Rasgon The Relationship Between Polycystic Ovary Syndrome and Antiepileptic Drugs: A Review of the Evidence , 2004, Journal of clinical psychopharmacology.

[31]  A. Auvinen,et al.  Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. , 2004, American journal of epidemiology.

[32]  E. Lieberman,et al.  The AED (antiepileptic drug) pregnancy registry: a 6-year experience. , 2004, Archives of neurology.

[33]  L. Holmes,et al.  Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? , 2004, American journal of obstetrics and gynecology.

[34]  E. Andermann,et al.  Epilepsy and pregnancy: an obstetric perspective. , 2004, American journal of obstetrics and gynecology.

[35]  B. Källén,et al.  Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation‐wide, population‐based register study , 2004, Acta paediatrica.

[36]  P. Pennell,et al.  The impact of pregnancy and childbirth on the metabolism of lamotrigine , 2004, Neurology.

[37]  V. Hiilesmaa,et al.  Normal intelligence in children with prenatal exposure to carbamazepine , 2004, Neurology.

[38]  M. Dam,et al.  Epilepsy and pregnancy: lamotrigine as main drug used , 2004, Acta neurologica Scandinavica.

[39]  B. Källén,et al.  Anticonvulsant drugs and malformations is there a drug specificity? , 1989, European Journal of Epidemiology.

[40]  B. Källén,et al.  Anticonvulsant drugs in monotherapy. Effect on the fetus , 1987, European Journal of Epidemiology.

[41]  R. Bertollini,et al.  Maternal epilepsy and birth defects: A case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC) , 1985, European Journal of Epidemiology.

[42]  E. Pschirrer Seizure disorders in pregnancy. , 2004, Obstetrics and gynecology clinics of North America.

[43]  T. Einarson,et al.  Malformation Rates in Children of Women with Untreated Epilepsy , 2004, Drug safety.

[44]  Julian N. Robinson,et al.  Screening for fetal heart disease with ultrasound. , 2003, Clinical obstetrics and gynecology.

[45]  D. Petitti Combination Estrogen–Progestin Oral Contraceptives , 2003 .

[46]  T. O'Brien,et al.  The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months , 2003, Journal of Clinical Neuroscience.

[47]  C. Stoll,et al.  Prenatal diagnosis of dysmorphic syndromes by routine fetal ultrasound examination across Europe , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[48]  A. Richens,et al.  Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop , 2003, Epilepsy Research.

[49]  C. D'Giano,et al.  Major malformations in offspring of women with epilepsy. , 2003, Neurology.

[50]  D. Petitti Clinical practice. Combination estrogen-progestin oral contraceptives. , 2003, The New England journal of medicine.

[51]  J. Clayton-Smith,et al.  Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate , 2002, Seizure.

[52]  P. Genton,et al.  Epilepsy and women's issues: an update. , 2002, Epileptic disorders : international epilepsy journal with videotape.

[53]  T. Nelson,et al.  Prenatal evaluation of facial clefts with two-dimensional and adjunctive three-dimensional ultrasonography: a prospective trial. , 2002, American journal of obstetrics and gynecology.

[54]  T. Tomson,et al.  Psychomotor development in preschool children exposed to antiepileptic drugs in utero , 2002, Acta paediatrica.

[55]  J. Little,et al.  Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth , 2002, Journal of medical genetics.

[56]  H. Dolk,et al.  Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications , 2002, Journal of medical genetics.

[57]  V. Hiilesmaa,et al.  Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate , 2002, Neurology.

[58]  P. Doubilet,et al.  Prenatal ultrasonography and the diagnosis of fetal cleft lip. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[59]  A. Ornoy,et al.  Is carbamazepine teratogenic?: A prospective controlled study of 210 pregnancies , 2001 .

[60]  S. Hernández-Díaz,et al.  Neural tube defects in relation to use of folic acid antagonists during pregnancy. , 2001, American journal of epidemiology.

[61]  D. Battino Assessment of teratogenic risk , 2001, Epilepsy Research.

[62]  D. Chadwick,et al.  Additional educational needs in children born to mothers with epilepsy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[63]  G. Zampino,et al.  Teratogenic Effects of Antiepileptic Drugs: Use of an International Database on Malformations and Drug Exposure (MADRE) , 2000, Epilepsia.

[64]  C. Comstock What to expect from routine midtrimester screening for congenital heart disease. , 2000, Seminars in perinatology.

[65]  D. Walshaw,et al.  Population based, prospective study of the care of women with epilepsy in pregnancy , 2000, BMJ : British Medical Journal.

[66]  M. Dam,et al.  Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight , 2000, BJOG : an international journal of obstetrics and gynaecology.

[67]  B. Källén,et al.  Body Dimensions of Infants Exposed to Antiepileptic Drugs In Utero: Observations Spanning 25 Years , 2000, Epilepsia.

[68]  L. Pedersen,et al.  Birth outcomes in women exposed to anticonvulsant drugs , 2000, Acta neurologica Scandinavica.

[69]  I. Arroyo,et al.  Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study. , 2000, American journal of medical genetics.

[70]  T. Tomson,et al.  Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population‐based study , 2000, Developmental medicine and child neurology.

[71]  G. Baker,et al.  The Stigma of Epilepsy: A European Perspective , 2000, Epilepsia.

[72]  A. Hofman,et al.  Antiepileptic drug regimens and major congenital abnormalities in the offspring , 1999, Annals of neurology.

[73]  U. Lehmkuhl,et al.  Long‐Term Neuropsychological Consequences of Maternal Epilepsy and Anticonvulsant Treatment During Pregnancy for School‐Age Children and Adolescents , 1999, Epilepsia.

[74]  G. Avanzini,et al.  Malformations in Offspring of Women with Epilepsy: A Prospective Study , 1999, Epilepsia.

[75]  G. Avanzini,et al.  Intrauterine growth in the offspring of epileptic women: a prospective multicenter study , 1999, Epilepsy Research.

[76]  G. Avanzini,et al.  Congenital malformations due to antiepileptic drugs , 1999, Epilepsy Research.

[77]  K. Nicolaides,et al.  Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study , 1999, BMJ.

[78]  U. Lehmkuhl,et al.  Epilepsy and Neuropsychological Consequences of Maternal Anticonvulsant Treatment During Pregnancy for School-Age Children and Adolescents , 1999 .

[79]  Practice Parameter: Management Issues for Women with Epilepsy (Summary Statement) , 1998, Epilepsia.

[80]  M. Dam,et al.  Pregnancy and Epilepsy: A Retrospective Study of 151 Pregnancies , 1998 .

[81]  W. Hauser,et al.  Pregnancies of Women with Epilepsy: A Population‐Based Study in Iceland , 1998, Epilepsia.

[82]  C. Zahn Neurologic Care of Pregnant Women with Epilepsy , 1998, Epilepsia.

[83]  S. Tanaka,et al.  Heterogeneity of Ictal SPECT Findings in Nine Cases of West Syndrome , 1998, Epilepsia.

[84]  S. Broman,et al.  Maternal and neonatal risk factors for mental retardation: defining the 'at-risk' child. , 1998, Early human development.

[85]  A. Hofman,et al.  Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy , 1997, Epilepsia.

[86]  S. Jick,et al.  Anticonvulsants and Congenital Malformations , 1997, Pharmacotherapy.

[87]  A. Ornoy,et al.  Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. , 1996, Archives of disease in childhood.

[88]  D. Rubin,et al.  In utero exposure to phenobarbital and intelligence deficits in adult men. , 1995, JAMA.

[89]  G. Koren,et al.  Effects of maternal epilepsy on children's neurodevelopment , 1995 .

[90]  A. Dessens,et al.  Studies on long‐lasting consequences of prenatal exposure to anticonvulsant drugs , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[91]  H. Steinhausen,et al.  The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors , 1994, Acta paediatrica.

[92]  H. Steinhausen,et al.  The psychological development of children of epileptic parents. I. Study design and comparative findings , 1994, Acta paediatrica.

[93]  G. Borm,et al.  Factors influencing the risk of abnormal pregnancy outcome in epileptic women: A multi-centre prospective study , 1994, Epilepsy Research.

[94]  R. Weksberg,et al.  Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. , 1994, JAMA.

[95]  C. Waters,et al.  Outcomes of pregnancy associated with antiepileptic drugs. , 1994, Archives of neurology.

[96]  T. Tomson,et al.  Epilepsy and Pregnancy: A Prospective Study of Seizure Control in Relation to Free and Total Plasma Concentrations of Carbamazepine and Phenytoin , 1994, Epilepsia.

[97]  Vidović Mi,et al.  Trimestral changes of seizure frequency in pregnant epileptic women. , 1994 .

[98]  M. Vidović,et al.  Trimestral changes of seizure frequency in pregnant epileptic women. , 1994, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[99]  M. Khoury,et al.  The contribution of maternal epilepsy and its treatment to the etiology of oral clefts: A population based case‐control study , 1994, Genetic epidemiology.

[100]  V. Myllylä,et al.  Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. , 1994, The New England journal of medicine.

[101]  Z. Blumenfeld,et al.  The early diagnosis of neural tube defects , 1993, Prenatal diagnosis.

[102]  J. Hopper,et al.  The effect of pregnancy on the epilepsies: a study of 37 pregnancies. , 1993, Australian and New Zealand journal of medicine.

[103]  F. Andermann,et al.  Improved pregnancy outcome in epileptic women in the last decade: Relationship to maternal anticonvulsant therapy , 1992, Brain and Development.

[104]  L. Holmes,et al.  The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. , 1992, Neurotoxicology and teratology.

[105]  S. Aslan,et al.  Antiepileptic therapy and teratogenicity in Turkey. , 1992, International journal of clinical pharmacology, therapy, and toxicology.

[106]  C. J. Sells,et al.  Epilepsy in pregnancy: developmental outcome of offspring at 12 months. , 1992, Neurology.

[107]  D. Grobbee,et al.  The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. , 1992, Neurology.

[108]  G. Regesta,et al.  Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. , 1992, Neurology.

[109]  M. Yerby,et al.  Antiepileptic drug disposition during pregnancy. , 1992, Neurology.

[110]  D. Rating,et al.  Major and minor birth malformations and antiepileptic drugs. , 1992, Neurology.

[111]  G. Trentin,et al.  Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. , 1992, Neurology.

[112]  A. Delgado-Escueta,et al.  Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. , 1992, Neurology.

[113]  K. Otani,et al.  Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. , 1992, Neurology.

[114]  H. Nau,et al.  Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. , 1992, Neurology.

[115]  R. Loewenson,et al.  Antiepileptics and the development of congenital anomalies. , 1992, Neurology.

[116]  M. Schertzer,et al.  A polymorphic complex dinucleotide repeat at the telomeric D8S7 locus. , 1992, Human heredity.

[117]  M. Hadders‐Algra,et al.  Antiepileptic medication in pregnancy: Late effects on the children's central nervous system development , 1991, American journal of obstetrics and gynecology.

[118]  M. Yerby Pregnancy and Epilepsy , 1991, Epilepsia.

[119]  B. Abdulwahab,et al.  Congenital malformations before and after the onset of maternal epilepsy , 1991, Acta neurologica Scandinavica.

[120]  M. Eadie,et al.  Plasma Antiepileptic Drug Concentrations During Pregnancy , 1991, Epilepsia.

[121]  F. Rosa,et al.  Spina bifida in infants of women treated with carbamazepine during pregnancy. , 1991, The New England journal of medicine.

[122]  G. Mawer,et al.  Fetal phenytoin exposure, hypoplastic nails, and jitteriness. , 1991, Archives of disease in childhood.

[123]  N. Hotham,et al.  Epilepsy and Pregnancy ‐ A Review of 98 Pregnancies , 1990, The Australian & New Zealand journal of obstetrics & gynaecology.

[124]  M. Eadie,et al.  Antiepileptic drug intake during pregnancy and malformed offspring , 1990, Epilepsy Research.

[125]  E. Gaily,et al.  SPECIFIC COGNITIVE DYSFUNCTION IN CHILDREN WITH EPILEPTIC MOTHERS , 1990, Developmental medicine and child neurology.

[126]  C. J. Sells,et al.  Pharmacokinetics of anticonvulsants in pregnancy: Alterations in plasma protein binding , 1990, Epilepsy Research.

[127]  James W. P. Campbell,et al.  Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida. , 1990, American journal of obstetrics and gynecology.

[128]  E. Gaily,et al.  A transient retardation of early postnatal growth in drug-exposed children of epileptic mothers , 1989, Epilepsy Research.

[129]  K. Jones,et al.  Pattern of malformations in the children of women treated with carbamazepine during pregnancy. , 1989, The New England journal of medicine.

[130]  I. O. Gjerde,et al.  The course of epilepsy during pregnancy: a study of 78 cases. , 1989, Acta neurologica Scandinavica.

[131]  E. Gaily,et al.  Intelligence of children of epileptic mothers. , 1988, The Journal of pediatrics.

[132]  M. Goto,et al.  Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk Factors , 1988, Epilepsia.

[133]  A. Bardy Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study , 1987, Acta neurologica Scandinavica.

[134]  E. Perucca Drug metabolism in pregnancy, infancy and childhood. , 1987, Pharmacology & therapeutics.

[135]  D. Lindhout,et al.  IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTS , 1986, The Lancet.

[136]  H. Nau,et al.  Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. , 1986, The Journal of pediatrics.

[137]  B. Källén,et al.  A register study of maternal epilepsy and delivery outcome with special reference to drug use , 1986, Acta neurologica Scandinavica.

[138]  Sheryl M. Davies Epilepsy and pregnancy. , 1927, American family physician.

[139]  J. Opitz,et al.  Teratogenicity of anticonvulsant drugs. , 1985, American journal of medical genetics.

[140]  M. Friis,et al.  Congenital heart defects in live-born children of epileptic parents. , 1985, Archives of neurology.

[141]  K. Otani Risk Factors for the Increased Seizure Frequency during Pregnancy and Puerperium , 1985, Folia psychiatrica et neurologica japonica.

[142]  S. Kaneko,et al.  100. The Physical and Mental Development of Infants Born to Mothers Treated with Antiepileptic Drugs , 1984 .

[143]  F. Dreifuss,et al.  Teratogenicity of anticonvulsant drugs. II: A prospective study. , 1984, American journal of medical genetics.

[144]  T. Kelly,et al.  Teratogenicity of anticonvulsant drugs. IV: The association of clefting and epilepsy. , 1984, American journal of medical genetics.

[145]  Wells Wt Definition of insanity. , 1984 .

[146]  D. Lindhout,et al.  SPINA BIFIDA AND IN-UTERO EXPOSURE TO VALPROATE , 1984, The Lancet.

[147]  D. Lindhout,et al.  Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine) , 1984, Epilepsia.

[148]  R. Guzmán Toledano,et al.  [Epilepsy, anticonvulsants and pregnancy]. , 1984, Ginecologia y obstetricia de Mexico.

[149]  D. Rating,et al.  [Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development]. , 2008, Deutsche medizinische Wochenschrift.

[150]  D. Chadwick Pharmacokinetics of anticonvulsants. , 1983, British journal of hospital medicine.

[151]  G. Avanzini,et al.  Change of seizure frequency in pregnant epileptic women. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[152]  J. Ellenberg,et al.  Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children , 1982, Neurology.

[153]  E. Robert,et al.  MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS , 1982, The Lancet.

[154]  E. Perucca,et al.  Plasma Protein Binding of Drugs in Pregnancy , 1982, Clinical pharmacokinetics.

[155]  G. Avanzini,et al.  Modifications of seizure frequency in pregnant patients with epilepsy a prospective study , 1982 .

[156]  V. Hiilesmaa,et al.  FETAL HEAD GROWTH RETARDATION ASSOCIATED WITH MATERNAL ANTIEPILEPTIC DRUGS , 1981, The Lancet.

[157]  F. Majewski,et al.  The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. , 1981, International journal of biological research in pregnancy.

[158]  K. Inanaga,et al.  Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan , 1980, Epilepsia.

[159]  R. Purcell,et al.  EPIDEMIC AND ENDEMIC HEPATITIS IN INDIA: EVIDENCE FOR A NON-A, NON-B HEPATITIS VIRUS ÆTIOLOGY , 1980, The Lancet.

[160]  M. Friis Epilepsy Among Parents of Children with Facial Clefts , 1979, Epilepsia.

[161]  M. Granström Development of the Children of Epileptic Mothers , 1979 .

[162]  V. Hiilesmaa,et al.  Fetal heart rate during a maternal grand mal epileptic seizure , 1979, Journal of perinatal medicine.

[163]  W. Hauser,et al.  Congenital malformations and seizure disorders in the offspring of parents with epilepsy. , 1978, International journal of epidemiology.

[164]  F. Martín [Pregnancy and epilepsy]. , 1978, Revue medicale de la Suisse romande.

[165]  A. Adelstein,et al.  Maternal drug histories and congenital abnormalities. , 1977, British medical journal.

[166]  M. Wéber,et al.  [Epilepsy, anticonvulsants and pregnancy]. , 1977, Archives francaises de pediatrie.

[167]  David W. Smith,et al.  Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. , 1976, The Journal of pediatrics.

[168]  Alasdair Breckenridge,et al.  Meyler's Side Effects of Drugs , 1976 .

[169]  G. Proud,et al.  ANAPHYLACTIC REACTION TO APROTININ , 1976, The Lancet.

[170]  S. Shapiro,et al.  Anticonvulsants and parental epilepsy in the development of birth defects. , 1976, Lancet.

[171]  A. H. Knight,et al.  Epilepsy and Pregnancy: A Study of 153 Pregnancies in 59 Patients , 1975, Epilepsia.

[172]  W. Hauser,et al.  Do anticonvulsants have a teratogenic effect? , 1974, Archives of neurology.

[173]  J. Erickson,et al.  Seizure disorder in mothers of children with orofacial clefts: a case-control study. , 1974, The Journal of pediatrics.

[174]  H. Meinardi,et al.  Are anticonvulsants teratogenic? , 1973, Lancet.

[175]  J. Fedrick Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study , 1973, British medical journal.

[176]  J. Meyer The teratological effects of anticonvulsants and the effects on pregnancy and birth. , 1973, European neurology.

[177]  S. Meadow,et al.  Maternal epilepsy and abnormalities of the fetus and newborn. , 1972, Lancet.

[178]  J. Elshove,et al.  [Congenital abnormalities, cleft lip and cleft palate in particular, in children of epileptic mothers]. , 1971, Nederlands tijdschrift voor geneeskunde.

[179]  K. Dronamraju Epilepsy and cleft lip and palate. , 1970, Lancet.

[180]  Broadhurst Ad L-tryptophan verses E.C.T. , 1970 .

[181]  A. Webb,et al.  Torulopsis glabrata septicaemia treated with 5-fluorocytosine. , 1970, Lancet.

[182]  S. Meadow,et al.  Congenital Abnormalities and Anticonvulsant Drugs , 1970, Proceedings of the Royal Society of Medicine.

[183]  Saunders Kb END--OR BEGINNING? , 1965 .

[184]  W. Jb Government service and freedom. , 1947 .